Unknown

Dataset Information

HOMA2-B enhances assessment of type 1 diabetes risk among TrialNet Pathway to Prevention participants.


ABSTRACT:

Aims/hypothesis

Methods to identify individuals at highest risk for type 1 diabetes are essential for the successful implementation of disease-modifying interventions. Simple metabolic measures are needed to help stratify autoantibody-positive (Aab+) individuals who are at risk of developing type 1 diabetes. HOMA2-B is a validated mathematical tool commonly used to estimate beta cell function in type 2 diabetes using fasting glucose and insulin. The utility of HOMA2-B in association with type 1 diabetes progression has not been tested.

Methods

Baseline HOMA2-B values from single-Aab+ (n = 2652; mean age, 21.1 ± 14.0 years) and multiple-Aab+ (n = 3794; mean age, 14.5 ± 11.2 years) individuals enrolled in the TrialNet Pathway to Prevention study were compared. Cox proportional

SUBMITTER: Felton JL 

PROVIDER: S-EPMC8752172 | biostudies-literature | 2022 Jan

REPOSITORIES: biostudies-literature